+

NO20076662L - Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff - Google Patents

Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff

Info

Publication number
NO20076662L
NO20076662L NO20076662A NO20076662A NO20076662L NO 20076662 L NO20076662 L NO 20076662L NO 20076662 A NO20076662 A NO 20076662A NO 20076662 A NO20076662 A NO 20076662A NO 20076662 L NO20076662 L NO 20076662L
Authority
NO
Norway
Prior art keywords
therapeutic antibody
malantigen
absence
independent
detection
Prior art date
Application number
NO20076662A
Other languages
English (en)
Norwegian (no)
Inventor
Helmut Lenz
Werner Scheuer
Martina Thier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20076662L publication Critical patent/NO20076662L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20076662A 2005-07-06 2007-12-28 Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff NO20076662L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05014618 2005-07-06
EP06004447 2006-03-06
PCT/EP2006/006524 WO2007003420A1 (fr) 2005-07-06 2006-07-05 Detection d'un antigene cible independamment de la presence ou de l'absence d'un anticorps therapeutique correspondant

Publications (1)

Publication Number Publication Date
NO20076662L true NO20076662L (no) 2008-04-03

Family

ID=36922121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076662A NO20076662L (no) 2005-07-06 2007-12-28 Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff

Country Status (19)

Country Link
US (1) US20070009976A1 (fr)
EP (2) EP2194380A3 (fr)
JP (1) JP2008545145A (fr)
KR (1) KR20080016939A (fr)
AR (1) AR053948A1 (fr)
AU (1) AU2006265275A1 (fr)
BR (1) BRPI0612591A2 (fr)
CA (1) CA2613187A1 (fr)
CR (1) CR9635A (fr)
EC (1) ECSP088081A (fr)
IL (1) IL188317A0 (fr)
MA (1) MA29730B1 (fr)
MX (1) MX2008000277A (fr)
MY (1) MY157955A (fr)
NO (1) NO20076662L (fr)
NZ (1) NZ564471A (fr)
RU (1) RU2008103608A (fr)
TW (1) TWI312864B (fr)
WO (1) WO2007003420A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2407556C (fr) * 2000-05-19 2011-06-21 Genentech, Inc. Analyse de detection genique permettant d'ameliorer la probabilite d'une reponse efficace a une therapie du cancer basee sur un antagoniste d'erbb
SI1771482T1 (sl) 2004-07-22 2014-12-31 Genentech, Inc. Sestavek HER2 protitelesa
EP2398223B1 (fr) 2004-10-01 2014-03-19 The Board Of Trustees Of The Leland Stanford Junior University Agencement d'imagerie et procédé correspondante
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
PL1850874T3 (pl) 2005-02-23 2014-03-31 Genentech Inc Wydłużanie czasu do progresji choroby lub przeżycia u chorych na raka jajnika stosujących pertuzumab
PE20070207A1 (es) * 2005-07-22 2007-03-09 Genentech Inc Tratamiento combinado de los tumores que expresan el her
US8248515B2 (en) 2006-02-07 2012-08-21 The Board Of Trustees Of The Leland Stanford Junior University Variable imaging arrangements and methods therefor
US8358354B2 (en) 2009-01-26 2013-01-22 The Board Of Trustees Of The Leland Stanford Junior University Correction of optical abberations
TWI352199B (en) 2007-03-02 2011-11-11 Genentech Inc Predicting response to a her inhibitor
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
BRPI0812682A2 (pt) 2008-06-16 2010-06-22 Genentech Inc tratamento de cáncer de mama metastático
CN116808199A (zh) 2011-10-14 2023-09-29 霍夫曼-拉罗奇有限公司 Her2二聚化抑制剂帕妥珠单抗的用途和包含her2二聚化抑制剂帕妥珠单抗的制品
KR101327542B1 (ko) * 2012-03-15 2013-11-08 광주과학기술원 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법
AU2012232949B2 (en) * 2012-09-28 2014-07-03 Willowtree Holdings Pty Ltd Temporary bulkhead
EP2986643A2 (fr) 2013-04-16 2016-02-24 F. Hoffmann-La Roche AG Variants de pertuzumab et leur évaluation
JP2017513901A (ja) 2014-04-25 2017-06-01 ジェネンテック， インコーポレイテッド トラスツズマブ−ｍｃｃ−ｄｍ１及びペルツズマブにより早期の乳癌を処置する方法
EP3302551B1 (fr) 2015-05-30 2024-06-26 F. Hoffmann-La Roche AG Methodes pour le traitement du cancer du sein her2-positive métastatique et précédemment non-traité
WO2017087280A1 (fr) 2015-11-16 2017-05-26 Genentech, Inc. Procédés de traitement d'un cancer positif her2
WO2018125589A1 (fr) 2016-12-28 2018-07-05 Genentech, Inc. Traitement du cancer exprimant her2 avancé
EP3570884B1 (fr) 2017-01-17 2020-09-30 Genentech, Inc. Formulations sous-cutanées d'anticorps her2
PT3589661T (pt) 2017-03-02 2024-01-29 Genentech Inc Tratamento com adjuvante de cancro da mama positivo para her2
WO2018200505A1 (fr) 2017-04-24 2018-11-01 Genentech, Inc. Mutations erbb2/her2 dans le domaine transmembranaire ou juxtamembranaire
IL299376A (en) 2020-06-29 2023-02-01 Genentech Inc Pertuzuniab plus trastuzumab fixed dose combination

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DE69233254T2 (de) * 1991-06-14 2004-09-16 Genentech, Inc., South San Francisco Humanisierter Heregulin Antikörper
WO1993021319A1 (fr) 1992-04-08 1993-10-28 Cetus Oncology Corporation ANTICORPS HUMANISES SPECIFIES PAR C-erbB-2
TR199901615T2 (en) 1996-10-18 1999-11-22 Genentech, Inc. Anti-ErbB2 antikorlar�.
JP4424987B2 (ja) * 2001-09-20 2010-03-03 ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム Ｅｌｉｓａアッセイを用いた循環する治療抗体、抗原および抗原／抗体複合体の測定
ES2392525T3 (es) * 2002-07-15 2012-12-11 F. Hoffmann-La Roche Ag Tratamiento del cáncer con el anticuerpo dirigido contra ErbB2 rhuMAb 2C4

Also Published As

Publication number Publication date
WO2007003420A1 (fr) 2007-01-11
EP1902315A1 (fr) 2008-03-26
MA29730B1 (fr) 2008-09-01
CA2613187A1 (fr) 2007-01-11
ECSP088081A (es) 2008-02-20
BRPI0612591A2 (pt) 2010-11-23
IL188317A0 (en) 2008-04-13
TWI312864B (en) 2009-08-01
EP2194380A2 (fr) 2010-06-09
EP2194380A3 (fr) 2010-07-14
US20070009976A1 (en) 2007-01-11
MY157955A (en) 2016-08-30
RU2008103608A (ru) 2009-08-20
NZ564471A (en) 2010-04-30
KR20080016939A (ko) 2008-02-22
AR053948A1 (es) 2007-05-23
JP2008545145A (ja) 2008-12-11
CR9635A (es) 2008-02-20
TW200741203A (en) 2007-11-01
AU2006265275A1 (en) 2007-01-11
MX2008000277A (es) 2008-03-24

Similar Documents

Publication Publication Date Title
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
MX2009013411A (es) Deteccion de antigenos transportados por eritrocitos y de anticuerpos anti-eritrocitos.
BRPI0519119A2 (pt) sistema colorimÉtrico e mÉtodo para detectar um analito
BRPI0809138B8 (pt) método para detectar a presença ou quantidade de um ou mais analitos em uma amostra biológica
WO2008070229A3 (fr) Détection d'agrégats pathogènes de protéine dans un échantillon par elisa homologue
NZ609824A (en) Immunochromatography devices, methods and kits
WO2013074520A3 (fr) Détection, isolement et analyse de cellules rares dans des liquides biologiques
NZ609363A (en) Methods for determining anti-drug antibody isotypes
BRPI0906060A2 (pt) anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra
WO2010096674A3 (fr) Dosages de biomarqueur a+
FR2935384B1 (fr) Procede de detection du virus de la rougeole, dispositif et kit utilisant ce procede
RS54249B1 (en) PROCEDURE FOR DETECTION OF ANTI-MEDICINAL ANTIBODIES
WO2007024735A3 (fr) Methode et anticorps destines a detecter le nitrofurane
WO2008073895A3 (fr) Procédés et dispositifs d'analyse de la salive
MX2008000282A (es) Anticuerpos monoclonales, lineas celulares de hibridomas, metodos y kits para la deteccion de fitasa.
WO2006069023A3 (fr) Procede et appareil d'analyse avec effets de matrices d'echantillons reduits
MX353566B (es) Metodos y sistemas para amplificacion de señal de bioensayos.
WO2011008831A3 (fr) Marqueurs de masse pour l'analyse spectrométrique d'immunoglobulines
EA201370030A1 (ru) Бифункциональный количественный анализ in vitro связывания мишени для обнаружения нейтрализующих антител к антителам-мишеням
WO2009111572A3 (fr) Cellule, procédé et kit de réalisation d'un essai de neutralisation d'anticorps
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
WO2006099537A3 (fr) Utilisation de systemes d'antigenes a substituts d'anticorps a des fins de detection d'analytes
WO2011003598A3 (fr) Détection d'antigènes
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
WO2009044561A1 (fr) ANTICORPS MONOCLONAL ANTI-proNT/NMN

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载